Tag Archives: HHS

DOD, HHS to Procure More Doses of Regeneron’s COVID-19 Antibody Under Potential $2.6B Deal

COVID-19

Regeneron Pharmaceuticals (Nasdaq: REGN) will supply an additional 1.25M treatment courses of an antibody cocktail composed of casirivimab and imdevimab to the U.S. government under a potential $2.63B agreement with the departments of Defense and Health and Human Services.

Read More »

Jerry McGinn, Daniel Kaniewski: New Administration Should Strengthen Law on Domestic Industrial Base Resources

Jerry McGinn GovCon Expert

The incoming administration of President-elect Joe Biden should build on executive actions implemented under the Defense Production Act amid the coronavirus pandemic and expand DPA authorities to further support the country's industrial base, Jerry McGinn, executive director of George Mason University's Center for Government Contracting, wrote in a joint commentary with Marsh and McLennan managing director Daniel Kaniewski.

Read More »